Upper GI (L4) involvement at CD diagnosis

reported prevalence of upper GI (L4) crohn's involvement varies enormously with how it is ascertained: classically symptomatic/clinically-defined L4 is quoted at ~0.3–5% of CD patients ^1,2, but systematic endoscopic and histologic screening detects it far more often, 16–34% in adult italian/american cohorts, and up to ~41% (gastric antrum) histologically, with some series reaching >50% ^3–5. these figures are prevalence in mixed populations rather than specifically "at diagnosis," and the excerpts do not give a clean at-diagnosis rate. ^1–5

What is known:

• Clinically/symptomatically defined upper GI CD (L4) is historically reported in only 0.3–5% of patients. ^1,2
• Prospective endoscopic screening irrespective of symptoms yields much higher L4 prevalence; adult italian/american studies report 16–34%. ^3,5
• Histologic study of 792 CD patients found disease in the gastric antrum in 41.5%, body 37.1%, duodenum 12.1%; some series report up to ~54%. ^3,4
• Pediatric cohorts also report high upper-GI involvement (50.0%, 26/52, in one Korean multicenter series). ⁵

What is unknown / caveats:

• Symptom-defined L4 (0.3–5%) vs endoscopy/histology-defined L4 (16–>50%) differ by an order of magnitude
• L4 lumps EGD, jejunal, and proximal-ileal disease, which behave differently
• Excerpts give prevalence in mixed/prevalent populations, not a specific at-diagnosis rate
• Estimates depend heavily on ascertainment method, population (asian vs caucasian), and adult vs pediatric
• The corpus does not provide a single at-diagnosis proportion; the answer depends on whether L4 is defined clinically or by endoscopic/histologic screening.

References

1. Moon JS, Lee JL, Yu CS, Lim SB, Park IJ, Yoon YS, Kim CW, Yang SK, Ye BD, Park SH, Alsaleem HA, Kim JC. Clinical Characteristics and Postoperative Outcomes of Patients Presenting With Upper Gastrointestinal Tract Crohn Disease. Ann Coloproctol. 2020;36(4):243-248. PMID: 32178500.

2. Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci. 2012. PMID: 22350786.

3. Graca-Pakulska K, Błogowski W, Zawada I, Deskur A, Dąbkowski K, Urasińska E, Starzyńska T. Endoscopic findings in the upper gastrointestinal tract in patients with Crohn's disease are common, highly specific, and associated with chronic gastritis. Sci Rep. 2023. PMID: 36639398.

4. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch. 1998. PMID: 9463587.

5. Park JH, Nam HN, Lee JH, Hong J, Yi DY, Ryoo E, Jeon IS, Tchah H. Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn's Disease: A Multicenter Study. Pediatr Gastroenterol Hepatol Nutr. 2017. PMID: 29302504.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.